Keywords: Thiabendazole, Cancer therapy potential, Antifungal, University of Texas at Austin

Common antifungal drug thiabendazole shows promise as cancer therapy

Article | 21 August 2012

An inexpensive US Food and Drug Administration approved antifungal drug, thiabendazole, slows tumor growth and shows promise as a chemotherapy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

thiabendazole

Go to drug listing